Health Secretary Robert F. Kennedy Jr. has drawn fresh controversy after again suggesting a possible link between the painkiller Tylenol and autism during a Cabinet meeting with Donald Trump.
Despite acknowledging there is no confirmed medical evidence, Kennedy reiterated his long-standing theory and made additional claims that experts quickly criticized.
Medical professionals and public health organizations have repeatedly stated there is no proven connection between acetaminophen (Tylenol) use during pregnancy and autism. The drug’s manufacturer also rejected the allegations, while advocacy groups called the comments “dangerous” and “misleading.”
During the meeting, Kennedy insisted research was ongoing but warned against use during pregnancy unless necessary. He also made several statements that drew criticism from experts, including inaccurate references to pregnancy anatomy and previously debunked studies.
The remarks have reignited concern among scientists and public health officials, who say such claims risk spreading misinformation and undermining trust in established medical guidance.
Leave a Reply